Deals Digest: Riverside invests in Avance Clinical; EasySend nets $51m

Photo: REUTERS/Beawiharta

Global investment firm The Riverside Company has invested in Avance Clinical, an Australian contract research organisation, while Israel’s EasySend raised $50.5 million in funding.

The Riverside Company invests in Australia’s Avance Clinical

Global investment firm The Riverside Company has invested an undisclosed amount in Avance Clinical (Avance), an Australian contract research organisation (CRO) for international biotech firms, according to an announcement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter